SU997084A1 - Method of simulating peritonitis - Google Patents
Method of simulating peritonitis Download PDFInfo
- Publication number
- SU997084A1 SU997084A1 SU813278177A SU3278177A SU997084A1 SU 997084 A1 SU997084 A1 SU 997084A1 SU 813278177 A SU813278177 A SU 813278177A SU 3278177 A SU3278177 A SU 3278177A SU 997084 A1 SU997084 A1 SU 997084A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- peritonitis
- simulating
- suspension
- feces
- appendicitis
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Изобретение относитс к медицине, а именно к способам получени моделей перитонита дл изучени егр развити , течени и лечени .The invention relates to medicine, in particular, to methods for producing models of peritonitis for the study of the rate of development, course and treatment.
Известен способ моделировани перитонита путем введени 30%-ной суспензии кала в бркшную полость tlj.There is a known method for simulating peritonitis by introducing a 30% fecal suspension into the tumor cavity tlj.
Однако при Применении известного способа попадание патогенного раздражител в полость брюшины приводит к шоковой, реакции и гибели животных, а введение суспензии кала собаки, где реакци микрофлоры на лекарственные препараты недостаточно исследована, затрудн ет изучение йеритонита в услови х- медикоментозной терапии.However, when using a known method, the penetration of a pathogenic irritant into the peritoneal cavity leads to shock, reaction and death of animals, and the introduction of a dog feces suspension, where the response of microflora to drugs is insufficiently investigated, makes it difficult to study yeritonitis under conditions of medication and chemotherapy.
Целью изобретени вл етс приближение искусственной патологии к клиническому течению заболевани у человека , адекватному осложнению аппендицита и холецистита..The aim of the invention is the approximation of an artificial pathology to the clinical course of the disease in humans, adequate to the complication of appendicitis and cholecystitis ..
Цель достигаетс -тем, что при мо;делировании перитонита путем введени 30%-нЬй суспензии кала в брюшную полость суспензию кала ввод т в дозе 1-2 мл/кг веса животного в толщу па риетальной бркшины .и в предбришинную клетчатку. The goal is achieved by the fact that when modeling peritonitis by introducing a 30% suspension of feces into the abdominal cavity, the suspension of feces is administered at a dose of 1-2 ml / kg of animal weight into the thickness of the respiratory tissue.
Способ осуществл ют следующим образом .The method is carried out as follows.
В r v6oKHe слои брюшины и предбрют In r v6oKHe layers of peritoneum and prebryut
шинную клетчатку н шне-боковыз сте-. нок живота животного, например собаки , на фоне измененной реактивности . организма ввод т патогенный раздражитель , HanpHfdep суспензию кала человека . Вводима доза составл ет .1-2 мл на 1 кг веса животного. А дл предупреждени возможной перфорации tire tissue n shne-bozor st. Nok stomach animal, such as dogs, on the background of altered reactivity. pathogenic stimulus, HanpHfdep human feces suspension is administered to the body. The injected dose is. 1-2 ml per kg of animal weight. And to prevent possible perforation
10 бргалины стенку животного послойно .: : рассекают до серозного покрова и под,. контролем зрени 30%-ную суспензию -: ввод т иглой в толщину брюшины и10 brgalina animal wall layers.:: Cut through to the serous cover and under ,. vision control 30% suspension -: injected with a needle into the thickness of the peritoneum and
предбркшинную клетчаткуi .pre-breakthrough fiber.
1515
При введении патогенного раздражител создаютс услови , идентичные возникновению перитонита, которым ос;-; ложнились аппендицит и холецистит у человека. Дл преду1 ре)|здени возник 20 новени болевого шока и перитонналь ного сепсиса патогенный раздражитель ввод т не в полость бркшины, а локализуют в предбрмшинной клетчатке и глубоких сло х брюшины на ограничен25 ном участке ее и он не вызывает инт .енсивнох о раздражени рецепторного аппарата серозного покрова. При аппендиците и холецистите, осложнив ,шихс перитонитом, воспалительный With the introduction of a pathogenic stimulus, conditions are created that are identical to the occurrence of peritonitis with which os; -; lied appendicitis and cholecystitis in humans. To prevent the development of painful shock and peritoneal sepsis, the pathogenic stimulus is not introduced into the cavity of the brain, but is localized in the prebarum tissue and the deep layers of the peritoneum in a limited part of it and does not cause intense irritation of the receptor apparatus. serous cover. When appendicitis and cholecystitis, complicating, aggravated peritonitis, inflammatory
30 процес р сначала-локализуетс в ели30 process is first localized in spruce
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU813278177A SU997084A1 (en) | 1981-04-27 | 1981-04-27 | Method of simulating peritonitis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU813278177A SU997084A1 (en) | 1981-04-27 | 1981-04-27 | Method of simulating peritonitis |
Publications (1)
Publication Number | Publication Date |
---|---|
SU997084A1 true SU997084A1 (en) | 1983-02-15 |
Family
ID=20954272
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU813278177A SU997084A1 (en) | 1981-04-27 | 1981-04-27 | Method of simulating peritonitis |
Country Status (1)
Country | Link |
---|---|
SU (1) | SU997084A1 (en) |
-
1981
- 1981-04-27 SU SU813278177A patent/SU997084A1/en active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Beach | Morphine addiction in rats. | |
Jansen | The ketamine model of the near-death experience: A central role for the N-methyl-D-aspartate receptor | |
FORRER et al. | Atropine coma: a somatic therapy in psychiatry | |
Whitehouse | Effects of atropine on discrimination learning in the rat. | |
US3484521A (en) | Enhancement of memory processes in mammals with basic addition salts of ribonucleic acid | |
Smith | The characteristics of dependence in high-dose methamphetamine abuse | |
SU997084A1 (en) | Method of simulating peritonitis | |
Yoxall | Pain in small animals–its recognition and control | |
Funderburk et al. | Effect of parasympathetic drugs on the conditioned response | |
Phillips et al. | Blockade of sensitisation-induced facilitation of appetitive conditioning by post-session intra-amygdala nafadotride | |
CN112569237B (en) | Application of combination or compound of imatinib and derivatives thereof and nicotine or analogues thereof in preventing and treating nicotine addiction and relapse | |
Helmstetter et al. | The beta-carboline DMCM produces hypoalgesia after central administration | |
RU2151427C1 (en) | Method for modeling acute peritonitis | |
Maier et al. | Dissociation of interference with the speed and accuracy of escape produced by inescapable shock. | |
McCrindle, Cheryl ME, Ebedes, H. & Swan | The use of long-acting neuroleptics, perphenazine enanthate and pipothiazine palmitate in two horses | |
OSBORNE et al. | The effect of arsenic on rabbits: Microchemical studies following the administration of the arsphenamines and tryparsamide | |
SU1767518A1 (en) | Method for simulating hemorrhagic cerebral thrombosis | |
O'brien et al. | Preparation of injectable dantrolene for emergency treatment of malignant hyperthermia-like syndromes | |
Kasckow et al. | Performance factors in regard to impaired memory and tolerance induced by atropine sulfate | |
SU1629916A1 (en) | Method of modelling diabetes mellitus | |
SU1545243A1 (en) | Method of simulating peritonitis | |
SU1562953A1 (en) | Method of modeling psychomotor paroxysms | |
SU1506472A1 (en) | Method of simulating pathological scratching reflex | |
Green et al. | Effects of centrifugal rotation on analgesia and conditioned flavor aversions | |
CN101632653A (en) | BAPTA and application of derivant thereof in preparing analgesic drugs |